Clinical trial
Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery
NCT00333567 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00333567 |
|---|---|
| Title | Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Compare Efficacy of a Single Dose of Lumiracoxib 400 mg Given Pre-Emptively Versus Post-Operatively, in Reducing Pain Associated With Ambulatory Arthroscopic Knee Surgery |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | Lumiracoxib |
| Enrollment | 110 |
| Start date | Aug 1, 2006 |
| First posted | Jun 5, 2006 |
| Last update posted | Dec 13, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: